One presenter said there is sufficient evidence supporting atropine to slow myopia progression. Another said inconsistent study designs do not support atropine as the standard of care. SEVILLE ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and ...

Atropine sulfate 1%; oph soln ... Nursing mothers. MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to ...

Source Reference: Loughman J, et al "Efficacy and safety of different atropine regimens for the treatment of myopia in children: three-year results of the MOSAIC randomized clinical trial" JAMA ...

The study contradicts earlier studies from East Asia that showed the small dose of atropine is effective in slowing progression of myopia. In 2017 the Academy of Ophthalmology endorsed the ...

Please provide your email address to receive an email when new articles are posted on . Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet ...

Repka reported receiving grants from the National Eye Institute and co-chairing a study of low-dose atropine treatment for myopia control. Source Reference: Repka MX "Atropine eye drops for myopia ...

SYD-101 contains a low dose of atropine sulfate ... 2025 has been assigned to the application. MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians ...